ReP USP - Resultado da busca

Artigo de periodico
Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi (2024)
Prates, João Lucas Bruno; Lopes, Juliana Romano ; Chin, Chung Man ; Ferreira, Elizabeth Igne ; Santos, Jean Leandro dos ; Scarim, Cauê Benito
Fonte: Current Medicinal Chemistry. Unidade: FCF
Assuntos: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 25 abr. 2024.
APA
Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
NLM
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 abr. 25 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Vancouver
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 abr. 25 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Artigo de periodico
Biomarkers in hypertension and hypertension-related disorders (2023)
Ribeiro, Patrícia de Carvalho ; Oliveira, Lucas Felipe; Mendes Filho, Daniel ; Parreira, Ricardo Cambraia; Vieira, Mariana Sousa; Marques, Bruno Lemes; Freitas, Elis Marra da Madeira; Silva, Walison N; Santiago, Helton da Costa ; Birbrair, Alexander ; Ulrich, Henning ; Silva, Valdo José Dias da; Resende, Rodrigo R
Fonte: Current Medicinal Chemistry. Unidade: IQ
Assuntos: BIOMARCADORES, HIPERTENSÃO, DOENÇAS CARDIOVASCULARES, METABOLÔMICA, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Patrícia de Carvalho et al. Biomarkers in hypertension and hypertension-related disorders. Current Medicinal Chemistry, v. 30, n. 34, p. 3846-3879, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220921113403. Acesso em: 25 abr. 2024.
APA
Ribeiro, P. de C., Oliveira, L. F., Mendes Filho, D., Parreira, R. C., Vieira, M. S., Marques, B. L., et al. (2023). Biomarkers in hypertension and hypertension-related disorders. Current Medicinal Chemistry, 30( 34), 3846-3879. doi:10.2174/0929867329666220921113403
NLM
Ribeiro P de C, Oliveira LF, Mendes Filho D, Parreira RC, Vieira MS, Marques BL, Freitas EM da M, Silva WN, Santiago H da C, Birbrair A, Ulrich H, Silva VJD da, Resende RR. Biomarkers in hypertension and hypertension-related disorders [Internet]. Current Medicinal Chemistry. 2023 ; 30( 34): 3846-3879.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867329666220921113403
Vancouver
Ribeiro P de C, Oliveira LF, Mendes Filho D, Parreira RC, Vieira MS, Marques BL, Freitas EM da M, Silva WN, Santiago H da C, Birbrair A, Ulrich H, Silva VJD da, Resende RR. Biomarkers in hypertension and hypertension-related disorders [Internet]. Current Medicinal Chemistry. 2023 ; 30( 34): 3846-3879.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867329666220921113403
Artigo de periodico
DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease (2023)
Souza, Márcia Maria de; Cenci, Arthur Ribeiro; Teixeira, Kerolain Faoro; Machado, Valkiria; Mendes, Majory Christina Garcia; Gonçalves, Ana Elisa; Dalmagro, Ana Paula; Cazarin, Camila André; Ferreira, Leonardo Luiz Gomes ; Oliveira, Aldo Sena de ; Andricopulo, Adriano Defini
Fonte: Current Medicinal Chemistry. Unidade: IFSC
Assuntos: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220620162018. Acesso em: 25 abr. 2024.
APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Mendes, M. C. G., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018
NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Artigo de periodico
The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review (2022)
Cruz, Josiane Viana; Rosa, Joaquín Maria Campos; Kimani, Njogu Mark; Giuliatti, Silvana ; Santos, Cleydson Breno Rodrigues dos
Fonte: Current Medicinal Chemistry. Unidade: FMRP
Assuntos: INFLAMAÇÃO, ANTI-INFLAMATÓRIOS, TOXICOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Josiane Viana et al. The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review. Current Medicinal Chemistry, v. 29, n. 17, p. 3028-3049, 2022Tradução . . Disponível em: https://doi.org/10.2174/0929867328666210910125229. Acesso em: 25 abr. 2024.
APA
Cruz, J. V., Rosa, J. M. C., Kimani, N. M., Giuliatti, S., & Santos, C. B. R. dos. (2022). The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review. Current Medicinal Chemistry, 29( 17), 3028-3049. doi:10.2174/0929867328666210910125229
NLM
Cruz JV, Rosa JMC, Kimani NM, Giuliatti S, Santos CBR dos. The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review [Internet]. Current Medicinal Chemistry. 2022 ; 29( 17): 3028-3049.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867328666210910125229
Vancouver
Cruz JV, Rosa JMC, Kimani NM, Giuliatti S, Santos CBR dos. The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review [Internet]. Current Medicinal Chemistry. 2022 ; 29( 17): 3028-3049.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867328666210910125229
Artigo de periodico
Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells (2021)
Pepino, Rebeka de Oliveira ; Coelho, Fernanda; Janku, Tatiane Aparecida Buzanello ; Alencar, Diandra Pinheiro ; Azevedo Jr, Walter Figueira de ; Canduri, Fernanda
Fonte: Current Medicinal Chemistry. Unidade: IQSC
Assuntos: BIOQUÍMICA, BIOLOGIA MOLECULAR, NEOPLASIAS, DOENÇA DE ALZHEIMER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEPINO, Rebeka de Oliveira et al. Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells. Current Medicinal Chemistry, v. 28, p. 6846-6865, 2021Tradução . . Disponível em: https://doi.org/10.2174/092986732866621032912214. Acesso em: 25 abr. 2024.
APA
Pepino, R. de O., Coelho, F., Janku, T. A. B., Alencar, D. P., Azevedo Jr, W. F. de, & Canduri, F. (2021). Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells. Current Medicinal Chemistry, 28, 6846-6865. doi:10.2174/092986732866621032912214
NLM
Pepino R de O, Coelho F, Janku TAB, Alencar DP, Azevedo Jr WF de, Canduri F. Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells [Internet]. Current Medicinal Chemistry. 2021 ; 28 6846-6865.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/092986732866621032912214
Vancouver
Pepino R de O, Coelho F, Janku TAB, Alencar DP, Azevedo Jr WF de, Canduri F. Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells [Internet]. Current Medicinal Chemistry. 2021 ; 28 6846-6865.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/092986732866621032912214
Artigo de periodico
New molecular targets and strategies for antimalarial discovery (2019)
Aguiar, Anna Caroline Campos; Sousa, Lorena R. F.; Garcia, Célia Regina da Silva ; Oliva, Glaucius ; Guido, Rafael Victorio Carvalho
Fonte: Current Medicinal Chemistry. Unidades: IFSC, IB
Assuntos: DOENÇAS TROPICAIS ANIMAL, MALÁRIA, PLANEJAMENTO DE FÁRMACOS, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Anna Caroline Campos et al. New molecular targets and strategies for antimalarial discovery. Current Medicinal Chemistry, v. 26, n. 23, p. 4380-4402, 2019Tradução . . Disponível em: https://doi.org/10.2174/0929867324666170830103003. Acesso em: 25 abr. 2024.
APA
Aguiar, A. C. C., Sousa, L. R. F., Garcia, C. R. da S., Oliva, G., & Guido, R. V. C. (2019). New molecular targets and strategies for antimalarial discovery. Current Medicinal Chemistry, 26( 23), 4380-4402. doi:10.2174/0929867324666170830103003
NLM
Aguiar ACC, Sousa LRF, Garcia CR da S, Oliva G, Guido RVC. New molecular targets and strategies for antimalarial discovery [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4380-4402.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867324666170830103003
Vancouver
Aguiar ACC, Sousa LRF, Garcia CR da S, Oliva G, Guido RVC. New molecular targets and strategies for antimalarial discovery [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4380-4402.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867324666170830103003
Artigo de periodico
Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery (2019)
Morotti, Ana Luísa Malaco; Martins-Teixeira, Maristela Braga; Carvalho, Ivone
Fonte: Current Medicinal Chemistry. Unidade: FCFRP
Assuntos: IMUNOTERAPIA, PROTOZOA, FOSFOLIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOROTTI, Ana Luísa Malaco e MARTINS-TEIXEIRA, Maristela Braga e CARVALHO, Ivone. Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery. Current Medicinal Chemistry, v. 26, p. 4301-4322, 2019Tradução . . Disponível em: https://doi.org/10.2174/0929867324666170727110801. Acesso em: 25 abr. 2024.
APA
Morotti, A. L. M., Martins-Teixeira, M. B., & Carvalho, I. (2019). Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery. Current Medicinal Chemistry, 26, 4301-4322. doi:10.2174/0929867324666170727110801
NLM
Morotti ALM, Martins-Teixeira MB, Carvalho I. Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery [Internet]. Current Medicinal Chemistry. 2019 ; 26 4301-4322.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867324666170727110801
Vancouver
Morotti ALM, Martins-Teixeira MB, Carvalho I. Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery [Internet]. Current Medicinal Chemistry. 2019 ; 26 4301-4322.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867324666170727110801
Artigo de periodico
Potential Triazole-based molecules for the treatment of neglected diseases (2019)
Mantoani, Susimaire Pedersoli; Andrade, Peterson de; Chierrito, Talita Perez Cantuaria; Figueredo, Andreza da Silva ; Carvalho, Ivone
Fonte: Current Medicinal Chemistry. Unidade: FCFRP
Assuntos: LEISHMANIOSE CUTÂNEA, DOENÇAS NEGLIGENCIADAS, DOENÇA DE CHAGAS, MALÁRIA, TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANTOANI, Susimaire Pedersoli et al. Potential Triazole-based molecules for the treatment of neglected diseases. Current Medicinal Chemistry, v. 26, n. 23, p. 4403-4434, 2019Tradução . . Disponível em: https://doi.org/10.2174/0929867324666170727103901. Acesso em: 25 abr. 2024.
APA
Mantoani, S. P., Andrade, P. de, Chierrito, T. P. C., Figueredo, A. da S., & Carvalho, I. (2019). Potential Triazole-based molecules for the treatment of neglected diseases. Current Medicinal Chemistry, 26( 23), 4403-4434. doi:10.2174/0929867324666170727103901
NLM
Mantoani SP, Andrade P de, Chierrito TPC, Figueredo A da S, Carvalho I. Potential Triazole-based molecules for the treatment of neglected diseases [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4403-4434.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867324666170727103901
Vancouver
Mantoani SP, Andrade P de, Chierrito TPC, Figueredo A da S, Carvalho I. Potential Triazole-based molecules for the treatment of neglected diseases [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4403-4434.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867324666170727103901
Artigo de periodico-carta/editorial
Drug design and development for neglected diseases [Editorial] (2019)
Ferreira, Elizabeth Igne
Fonte: Current Medicinal Chemistry. Unidade: FCF
Assunto: DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Elizabeth Igne. Drug design and development for neglected diseases [Editorial]. Current Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/092986732623190927101548. Acesso em: 25 abr. 2024. , 2019
APA
Ferreira, E. I. (2019). Drug design and development for neglected diseases [Editorial]. Current Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/092986732623190927101548
NLM
Ferreira EI. Drug design and development for neglected diseases [Editorial] [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4298-4300.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/092986732623190927101548
Vancouver
Ferreira EI. Drug design and development for neglected diseases [Editorial] [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4298-4300.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/092986732623190927101548
Artigo de periodico
UDP-glucuronosyl transferases: structure, function and drug design studies (2018)
Mano, Erica Candido Costa; Scott, Ana Ligia; Honorio, Káthia Maria
Fonte: Current Medicinal Chemistry. Unidade: EACH
Assuntos: INTERAÇÃO DE MEDICAMENTOS, BIOINFORMÁTICA, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANO, Erica Candido Costa e SCOTT, Ana Ligia e HONORIO, Káthia Maria. UDP-glucuronosyl transferases: structure, function and drug design studies. Current Medicinal Chemistry, v. 25, n. 27, p. 3247-3255, 2018Tradução . . Disponível em: https://doi.org/10.2174/0929867325666180226111311. Acesso em: 25 abr. 2024.
APA
Mano, E. C. C., Scott, A. L., & Honorio, K. M. (2018). UDP-glucuronosyl transferases: structure, function and drug design studies. Current Medicinal Chemistry, 25( 27), 3247-3255. doi:10.2174/0929867325666180226111311
NLM
Mano ECC, Scott AL, Honorio KM. UDP-glucuronosyl transferases: structure, function and drug design studies [Internet]. Current Medicinal Chemistry. 2018 ; 25( 27): 3247-3255.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867325666180226111311
Vancouver
Mano ECC, Scott AL, Honorio KM. UDP-glucuronosyl transferases: structure, function and drug design studies [Internet]. Current Medicinal Chemistry. 2018 ; 25( 27): 3247-3255.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867325666180226111311
Artigo de periodico
Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells (2018)
Alves, Ana Carolina Schineider; Dias Júnior, Reinaldo Antonio; Kagami, Luciano Porto; Neves, Gustavo Machado das; Torres, Fernando Cidade; Eifler-Lima, Vera Lúcia; Carvalho, Ivone ; Silva, Carolina de Miranda; Kawano, Daniel Fábio
Fonte: Current Medicinal Chemistry. Unidade: FCFRP
Assuntos: APOPTOSE, ANTINEOPLÁSICOS, NEOPLASIAS, FOSFOLIPÍDEOS, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Ana Carolina Schineider et al. Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells. Current Medicinal Chemistry, v. 25, p. 2082-2104, 2018Tradução . . Disponível em: https://doi.org/10.2174/0929867325666180111100601. Acesso em: 25 abr. 2024.
APA
Alves, A. C. S., Dias Júnior, R. A., Kagami, L. P., Neves, G. M. das, Torres, F. C., Eifler-Lima, V. L., et al. (2018). Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells. Current Medicinal Chemistry, 25, 2082-2104. doi:10.2174/0929867325666180111100601
NLM
Alves ACS, Dias Júnior RA, Kagami LP, Neves GM das, Torres FC, Eifler-Lima VL, Carvalho I, Silva C de M, Kawano DF. Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells [Internet]. Current Medicinal Chemistry. 2018 ; 25 2082-2104.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867325666180111100601
Vancouver
Alves ACS, Dias Júnior RA, Kagami LP, Neves GM das, Torres FC, Eifler-Lima VL, Carvalho I, Silva C de M, Kawano DF. Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells [Internet]. Current Medicinal Chemistry. 2018 ; 25 2082-2104.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867325666180111100601
Artigo de periodico
The emerging picture of CDK11: genetic, functional and medicinal aspects (2017)
Paparidis, Nikolas Ferreira dos Santos; Canduri, Fernanda
Fonte: Current Medicinal Chemistry. Unidade: IQSC
Assunto: GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAPARIDIS, Nikolas Ferreira dos Santos e CANDURI, Fernanda. The emerging picture of CDK11: genetic, functional and medicinal aspects. Current Medicinal Chemistry, v. 24, p. xx-xx, 2017Tradução . . Disponível em: https://doi.org/10.2174/0929867324666170815102036. Acesso em: 25 abr. 2024.
APA
Paparidis, N. F. dos S., & Canduri, F. (2017). The emerging picture of CDK11: genetic, functional and medicinal aspects. Current Medicinal Chemistry, 24, xx-xx. doi:10.2174/0929867324666170815102036
NLM
Paparidis NF dos S, Canduri F. The emerging picture of CDK11: genetic, functional and medicinal aspects [Internet]. Current Medicinal Chemistry. 2017 ; 24 xx-xx.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867324666170815102036
Vancouver
Paparidis NF dos S, Canduri F. The emerging picture of CDK11: genetic, functional and medicinal aspects [Internet]. Current Medicinal Chemistry. 2017 ; 24 xx-xx.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867324666170815102036
Artigo de periodico
Nitric oxide’s involvement in the spectrum of psychotic disorders (2016)
Maia-de-Oliveira, João Paulo; Kandratavicius, Ludmyla; Nunes, Emerson Arcoverde; Machado-de-Sousa, João Paulo; Hallak, Jaime Eduardo Cecílio; Dursun, Serdar Murat
Fonte: Current Medicinal Chemistry. Unidade: FMRP
Assuntos: ANTIPSICÓTICOS, ARGININA, CÉREBRO, ÓXIDO NÍTRICO, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAIA-DE-OLIVEIRA, João Paulo et al. Nitric oxide’s involvement in the spectrum of psychotic disorders. Current Medicinal Chemistry, v. 23, n. 24, p. 2680-2691, 2016Tradução . . Disponível em: https://doi.org/10.2174/0929867323666160721144549. Acesso em: 25 abr. 2024.
APA
Maia-de-Oliveira, J. P., Kandratavicius, L., Nunes, E. A., Machado-de-Sousa, J. P., Hallak, J. E. C., & Dursun, S. M. (2016). Nitric oxide’s involvement in the spectrum of psychotic disorders. Current Medicinal Chemistry, 23( 24), 2680-2691. doi:10.2174/0929867323666160721144549
NLM
Maia-de-Oliveira JP, Kandratavicius L, Nunes EA, Machado-de-Sousa JP, Hallak JEC, Dursun SM. Nitric oxide’s involvement in the spectrum of psychotic disorders [Internet]. Current Medicinal Chemistry. 2016 ; 23( 24): 2680-2691.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867323666160721144549
Vancouver
Maia-de-Oliveira JP, Kandratavicius L, Nunes EA, Machado-de-Sousa JP, Hallak JEC, Dursun SM. Nitric oxide’s involvement in the spectrum of psychotic disorders [Internet]. Current Medicinal Chemistry. 2016 ; 23( 24): 2680-2691.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867323666160721144549
Artigo de periodico
Medicinal electrochemistry: integration of electrochemistry, medicinal chemistry and computational chemistry (2014)
Almeida, M. O; Maltarollo, Vinícius Gonçalves; Toledo, Renata Alves de; Shim, H; Santos, Mauro Coelho dos; Honório, Kathia Maria
Fonte: Current Medicinal Chemistry. Unidade: EACH
Assunto: ELETROQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, M. O et al. Medicinal electrochemistry: integration of electrochemistry, medicinal chemistry and computational chemistry. Current Medicinal Chemistry, v. 21, n. 20, p. 2266-2275, 2014Tradução . . Disponível em: https://doi.org/10.2174/0929867321666140217120655. Acesso em: 25 abr. 2024.
APA
Almeida, M. O., Maltarollo, V. G., Toledo, R. A. de, Shim, H., Santos, M. C. dos, & Honório, K. M. (2014). Medicinal electrochemistry: integration of electrochemistry, medicinal chemistry and computational chemistry. Current Medicinal Chemistry, 21( 20), 2266-2275. doi:10.2174/0929867321666140217120655
NLM
Almeida MO, Maltarollo VG, Toledo RA de, Shim H, Santos MC dos, Honório KM. Medicinal electrochemistry: integration of electrochemistry, medicinal chemistry and computational chemistry [Internet]. Current Medicinal Chemistry. 2014 ; 21( 20): 2266-2275.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867321666140217120655
Vancouver
Almeida MO, Maltarollo VG, Toledo RA de, Shim H, Santos MC dos, Honório KM. Medicinal electrochemistry: integration of electrochemistry, medicinal chemistry and computational chemistry [Internet]. Current Medicinal Chemistry. 2014 ; 21( 20): 2266-2275.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867321666140217120655
Artigo de periodico
Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but... how to deal with them? (2014)
Pereira, C. A.; Mayé, M.; Wrenger, Carsten ; Miranda, M. R.
Fonte: Current Medicinal Chemistry. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, C. A. et al. Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but.. how to deal with them?. Current Medicinal Chemistry, v. 21, n. 15, p. 1707-1712, 2014Tradução . . Acesso em: 25 abr. 2024.
APA
Pereira, C. A., Mayé, M., Wrenger, C., & Miranda, M. R. (2014). Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but.. how to deal with them? Current Medicinal Chemistry, 21( 15), 1707-1712.
NLM
Pereira CA, Mayé M, Wrenger C, Miranda MR. Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but.. how to deal with them? Current Medicinal Chemistry. 2014 ; 21( 15): 1707-1712.[citado 2024 abr. 25 ]
Vancouver
Pereira CA, Mayé M, Wrenger C, Miranda MR. Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but.. how to deal with them? Current Medicinal Chemistry. 2014 ; 21( 15): 1707-1712.[citado 2024 abr. 25 ]
Artigo de periodico-carta/editorial
Drug discovery for infectious agents causing neglected diseases (2014)
Silber, Ariel Mariano ; Pereira, Claudio A.; Wrenger, Carsten
Fonte: Current Medicinal Chemistry. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILBER, Ariel Mariano e PEREIRA, Claudio A. e WRENGER, Carsten. Drug discovery for infectious agents causing neglected diseases. Current Medicinal Chemistry. Schiphol: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 25 abr. 2024. , 2014
APA
Silber, A. M., Pereira, C. A., & Wrenger, C. (2014). Drug discovery for infectious agents causing neglected diseases. Current Medicinal Chemistry. Schiphol: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Silber AM, Pereira CA, Wrenger C. Drug discovery for infectious agents causing neglected diseases. Current Medicinal Chemistry. 2014 ; 21( 15): 1667.[citado 2024 abr. 25 ]
Vancouver
Silber AM, Pereira CA, Wrenger C. Drug discovery for infectious agents causing neglected diseases. Current Medicinal Chemistry. 2014 ; 21( 15): 1667.[citado 2024 abr. 25 ]
Artigo de periodico
MRSA infections: from classical treatment to suicide drugs (2014)
Drebes, Julia; Künz, Madeleine; Pereira, Claudio A.; Betzel, Christian; Wrenger, Carsten
Fonte: Current Medicinal Chemistry. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DREBES, Julia et al. MRSA infections: from classical treatment to suicide drugs. Current Medicinal Chemistry, v. 21, n. 15, p. 1809-1819, 2014Tradução . . Acesso em: 25 abr. 2024.
APA
Drebes, J., Künz, M., Pereira, C. A., Betzel, C., & Wrenger, C. (2014). MRSA infections: from classical treatment to suicide drugs. Current Medicinal Chemistry, 21( 15), 1809-1819.
NLM
Drebes J, Künz M, Pereira CA, Betzel C, Wrenger C. MRSA infections: from classical treatment to suicide drugs. Current Medicinal Chemistry. 2014 ; 21( 15): 1809-1819.[citado 2024 abr. 25 ]
Vancouver
Drebes J, Künz M, Pereira CA, Betzel C, Wrenger C. MRSA infections: from classical treatment to suicide drugs. Current Medicinal Chemistry. 2014 ; 21( 15): 1809-1819.[citado 2024 abr. 25 ]
Artigo de periodico
Biological implications of selenium and its role in trypanosomiasis treatment (2014)
Silva, M. T. A.; Jardim, I. Silva; Thiemann, Otávio Henrique
Fonte: Current Medicinal Chemistry. Unidade: IFSC
Assuntos: TRYPANOSOMA, SELÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, M. T. A. e JARDIM, I. Silva e THIEMANN, Otávio Henrique. Biological implications of selenium and its role in trypanosomiasis treatment. Current Medicinal Chemistry, v. 21, n. 15, p. 1772-1780, 2014Tradução . . Disponível em: https://doi.org/10.2174/0929867320666131119121108. Acesso em: 25 abr. 2024.
APA
Silva, M. T. A., Jardim, I. S., & Thiemann, O. H. (2014). Biological implications of selenium and its role in trypanosomiasis treatment. Current Medicinal Chemistry, 21( 15), 1772-1780. doi:10.2174/0929867320666131119121108
NLM
Silva MTA, Jardim IS, Thiemann OH. Biological implications of selenium and its role in trypanosomiasis treatment [Internet]. Current Medicinal Chemistry. 2014 ; 21( 15): 1772-1780.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867320666131119121108
Vancouver
Silva MTA, Jardim IS, Thiemann OH. Biological implications of selenium and its role in trypanosomiasis treatment [Internet]. Current Medicinal Chemistry. 2014 ; 21( 15): 1772-1780.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867320666131119121108
Artigo de periodico
In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms (2013)
Moraes, J; Keiser, James; Ingram, K; Nascimento, C; Yamaguchi, Lydia Fumiko; Bittencourt, C. R; Bemquerer, Marcelo Porto; Leite, J. R; Kato, Massuo Jorge ; Nakano, Eduardo
Fonte: Current Medicinal Chemistry. Unidade: IQ
Assuntos: SCHISTOSOMA MANSONI, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, J et al. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms. Current Medicinal Chemistry, v. 20, n. 2, p. 301-309, 2013Tradução . . Disponível em: http://www.sciencedirect.com/science/article/pii/S0731708512004876. Acesso em: 25 abr. 2024.
APA
Moraes, J., Keiser, J., Ingram, K., Nascimento, C., Yamaguchi, L. F., Bittencourt, C. R., et al. (2013). In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms. Current Medicinal Chemistry, 20( 2), 301-309. doi:10.1016/j.jpba.2012.08.028
NLM
Moraes J, Keiser J, Ingram K, Nascimento C, Yamaguchi LF, Bittencourt CR, Bemquerer MP, Leite JR, Kato MJ, Nakano E. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms [Internet]. Current Medicinal Chemistry. 2013 ; 20( 2): 301-309.[citado 2024 abr. 25 ] Available from: http://www.sciencedirect.com/science/article/pii/S0731708512004876
Vancouver
Moraes J, Keiser J, Ingram K, Nascimento C, Yamaguchi LF, Bittencourt CR, Bemquerer MP, Leite JR, Kato MJ, Nakano E. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms [Internet]. Current Medicinal Chemistry. 2013 ; 20( 2): 301-309.[citado 2024 abr. 25 ] Available from: http://www.sciencedirect.com/science/article/pii/S0731708512004876
Artigo de periodico
Chitosan nanoparticles for melanoma cancer treatment by photodynamic therapy and electrochemotherapy using aminolevulinic acid derivatives (2013)
Ferreira, D. M.; Saga, Y. Y.; Aluicio-Sarduy, E.; Tedesco, Antonio Claudio
Fonte: Current Medicinal Chemistry. Unidade: FFCLRP
Assuntos: RADIOTERAPIA, ELETROQUÍMICA (TERAPIA), NEOPLASIAS CUTÂNEAS, TERAPIA FOTODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, D. M. et al. Chitosan nanoparticles for melanoma cancer treatment by photodynamic therapy and electrochemotherapy using aminolevulinic acid derivatives. Current Medicinal Chemistry, v. 20, n. 14, p. 1904-1911, 2013Tradução . . Disponível em: https://doi.org/10.2174/0929867311320140007. Acesso em: 25 abr. 2024.
APA
Ferreira, D. M., Saga, Y. Y., Aluicio-Sarduy, E., & Tedesco, A. C. (2013). Chitosan nanoparticles for melanoma cancer treatment by photodynamic therapy and electrochemotherapy using aminolevulinic acid derivatives. Current Medicinal Chemistry, 20( 14), 1904-1911. doi:10.2174/0929867311320140007
NLM
Ferreira DM, Saga YY, Aluicio-Sarduy E, Tedesco AC. Chitosan nanoparticles for melanoma cancer treatment by photodynamic therapy and electrochemotherapy using aminolevulinic acid derivatives [Internet]. Current Medicinal Chemistry. 2013 ; 20( 14): 1904-1911.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867311320140007
Vancouver
Ferreira DM, Saga YY, Aluicio-Sarduy E, Tedesco AC. Chitosan nanoparticles for melanoma cancer treatment by photodynamic therapy and electrochemotherapy using aminolevulinic acid derivatives [Internet]. Current Medicinal Chemistry. 2013 ; 20( 14): 1904-1911.[citado 2024 abr. 25 ] Available from: https://doi.org/10.2174/0929867311320140007

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada